UPDATE: January 8, 2021 – Pharmascience Inc. recalls certain lots of over-the-counter ranitidine Pharmascience Inc. is recalling 13 additional lots of its store-brand over-the-counter ranitidine ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. The information provided on this page is intended ...
Appco Pharma LLC (Appco) is voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules to the Consumer level. Ranitidine Hydrochloride Capsules are being ...
For the second time this week, a drug manufacturer has recalled several lots of Ranitidine for too much NDMA, which laboratory tests have classified as a probable cancer-causing ingredient. But unlike ...
A list of recalled versions of ranitidine, the heartburn/digestive medication called “Zantac” in name-brand form, now includes Publix’s over-the-counter store brand. Publix Maximum Strength Ranitidine ...
Voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules in the US to the consumer level. Ranitidine Hydrochloride Capsules are being recalled because of ...
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity. The prophylactic strategy of ...
A voluntary recall of a generic version of Zantac has been issued because the drug has been found to contain a contaminant that could cause cancer. Sandoz Inc. is recalling 14 lots of prescription ...
SEMBACH KASERNE, Germany -- The U.S. Food and Drug Administration recently recommended a nationwide voluntary recall of Ranitidine (also known by its brand name, Zantac) for several ...
The electronic databases MEDLINE (1966 to July 2002), EMBASE (1978 to 2000) and the Cochrane Controlled Trials Register were searched using the text words and subject headings heartburn, ...
September 13, 2007, Hyderabad, India: Dr. Reddy’s Laboratories announced today, that the U.S. Food and Drug Administration (USFDA) has granted final approval for the Company’s Abbreviated New Drug ...
To earn CME related to this news article, click here. This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback